Stay updated on EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Sign up to get notified when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.

Latest updates to the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check18 days agoChange DetectedRemoved related topics: Prostate cancer and MedlinePlus Genetics from the page's related topics section, reducing access to ancillary disease and genetics information while leaving core study details intact.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded related topics links for Prostate cancer and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now shows Revision: v3.4.2; the older Revision: v3.4.1 and the government funding status notice were removed.SummaryDifference0.4%

- Check47 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that transactions may be delayed and the NIH Clinical Center remains open with status updates at cc.nih.gov and opm.gov. The site revision history shows an update from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.